ERBB2 and melanoma: This disparity can be due to the fact that both MDA-MB-HER2+ (Figure 5A) and the B16F10 melanoma (Figure 5C) xenografts exhibit necrotic features [52], resulting in decreased overall xenograft uptake [53].